Taking everything into account, SCTL scores 2 out of 10 in our fundamental rating. SCTL was compared to 190 industry peers in the Pharmaceuticals industry. SCTL has a bad profitability rating. Also its financial health evaluation is rather negative. SCTL is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

SCTL had negative earnings in the past year.
SCTL had a negative operating cash flow in the past year.
SCTL had negative earnings in each of the past 5 years.
In multiple years SCTL reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -8.64%, SCTL is in the better half of the industry, outperforming 74.37% of the companies in the same industry.
SCTL has a better Return On Equity (-22.61%) than 72.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-8.64%
ROE	-22.61%
ROIC	N/A

ROA(3y)-9.46%

ROA(5y)-14.37%

ROE(3y)-27.61%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SCTL has a Gross Margin (19.17%) which is in line with its industry peers.
SCTL's Gross Margin has declined in the last couple of years.
SCTL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	19.17%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1%

GM growth 5Y-15.39%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SCTL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SCTL has been increased compared to 1 year ago.
SCTL has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.24, we must say that SCTL is in the distress zone and has some risk of bankruptcy.
SCTL's Altman-Z score of -1.24 is in line compared to the rest of the industry. SCTL outperforms 48.74% of its industry peers.
SCTL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SCTL (0.01) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-1.24

ROIC/WACCN/A

WACC11.28%

2.3 Liquidity

SCTL has a Current Ratio of 1.07. This is a normal value and indicates that SCTL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SCTL (1.07) is worse than 85.93% of its industry peers.
A Quick Ratio of 0.86 indicates that SCTL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.86, SCTL is doing worse than 83.42% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.07
Quick Ratio	0.86

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.74% over the past year.
SCTL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.91%.
SCTL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.12% yearly.

EPS 1Y (TTM)40.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.71%

Revenue 1Y (TTM)4.91%

Revenue growth 3Y12.48%

Revenue growth 5Y4.12%

Sales Q2Q%14.16%

3.2 Future

Based on estimates for the next years, SCTL will show a very strong growth in Earnings Per Share. The EPS will grow by 31.13% on average per year.
The Revenue is expected to grow by 9.11% on average over the next years. This is quite good.

EPS Next Y45.81%

EPS Next 2Y27.18%

EPS Next 3Y31.13%

EPS Next 5YN/A

Revenue Next Year2.59%

Revenue Next 2Y4.69%

Revenue Next 3Y6.13%

Revenue Next 5Y9.11%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SCTL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SCTL. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCTL indicates a somewhat cheap valuation: SCTL is cheaper than 78.89% of the companies listed in the same industry.